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Abstract
Background: Recent reports suggest an increase in sexually-transmitted hepatitis C infection among HIV-
infected men who have sex with men (MSM) in European cities. We investigated whether current national
surveillance systems in England and Wales (E&W) are able to monitor sexual transmission of hepatitis C infection
among HIV-infected MSM.
Methods:  Routine laboratory reports of hepatitis C diagnoses and data from sentinel hepatitis C testing
surveillance were matched to HIV diagnosis reports to determine: (i) the number of MSM diagnosed with HIV
and hepatitis C (1996–2003); (ii) the number of HIV-diagnosed MSM tested for hepatitis C and found to be
positive at sentinel sites (2003).
Results: (i) Between 1996–2003, 38,027 hepatitis C diagnoses were reported; 25,938 (68%) were eligible for
matching with HIV diagnoses. Thirty-one men (four in London) had both a HIV and hepatitis C diagnosis where
the only risk was sex with another man. Numbers of "co-diagnosed" MSM increased from 0 in 1996 to 14 in 2003.
The majority of MSM (22/31) tested hepatitis C positive after HIV diagnosis. (ii) Of 78,058 test results from
sentinel hepatitis C testing sites in 2003, 67,712 (87%) were eligible for matching with HIV diagnoses. We
identified 242 HIV-diagnosed MSM who did not inject drugs who tested for hepatitis C in 2003; 11 (4.5%) tested
hepatitis C positive (95%CI: 2.3%–8.0%). Applying this percentage to all MSM seen for HIV-related care in E&W
in 2003, an estimated 680 MSM living with diagnosed HIV would have tested positive for sexually-transmitted
hepatitis C (95%CI: 346–1208).
Conclusion: Matching routine laboratory reports of hepatitis C diagnoses with HIV diagnoses only identified 31
HIV infected MSM with sexually-transmitted hepatitis C infection. Clinical studies suggest that this is an
underestimate. On the other hand, matching sentinel surveillance reports with HIV diagnoses revealed that in
E&W in 2003 nearly 5% of HIV-diagnosed MSM tested hepatitis C positive where the only risk was sex with
another man. Reports of sexually-transmitted hepatitis C infection were not confined to London. Enhanced
surveillance is needed to monitor sexually-transmitted hepatitis C among HIV-infected MSM in E&W.
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Background
There have been recent reports of an increase in sexually-
transmitted hepatitis C infection among HIV positive men
who have sex with men (MSM) in London and other
European cities [1-5]. Historically, sex between men has
accounted for relatively few cases of hepatitis C, with most
hepatitis C infections being acquired through injecting
drug use [6]. National surveillance of HIV and hepatitis C
infections reflects this historical picture, with diagnoses of
HIV and hepatitis C and sentinel surveillance of hepatitis
C testing being monitored by separate systems. For rea-
sons of confidentiality, HIV status is not recorded for hep-
atitis C diagnoses, and hepatitis C status has not been
systematically collected for HIV diagnoses. Co-infection is
only routinely monitored for injecting drug users through
an unlinked anonymous survey [7].
Evidence of an increase in sexually transmitted hepatitis C
infections among HIV-infected MSM in England and
Wales (E&W) comes from clinical studies only, mainly
confined to London and the south east of England [1,8].
At a central London sexual health clinic, Browne et al iden-
tified 26 HIV positive MSM with sexually transmitted hep-
atitis C infection between 1997 and 2002. More recently,
between October 2002 and August 2005, Danta et al
reported on 225 HIV positive MSM with sexually trans-
mitted hepatitis C seen in six large London genito-urinary
medicine (GUM) clinics and one in Brighton [1,8]. Hepa-
titis C infections among HIV positive MSM appear to be
associated with the following: unprotected anal inter-
course; non-injecting drug use; concurrent sexually trans-
mitted infections; and mucosally traumatic practices such
as fisting, which may result in parenteral transmission
[2,4,5,8]. HIV infection itself, may facilitate hepatitis C
infection by promoting viral receptivity and increasing
levels of hepatitis C RNA in semen [9,10]. Transmission of
hepatitis C among HIV-negative MSM however, still
appears to be rare [11,12].
While clinical studies suggest a rising number of sexually
transmitted hepatitis C infections among previously diag-
nosed HIV-infected MSM it is unclear as to whether this is
a national phenomenon and, if so, the extent to which
this is happening across E&W. Unfortunately there is cur-
rently no single national surveillance system that can
monitor HIV-hepatitis C co-infection among MSM. Since
the same patient information (soundex code of surname
[13], date of birth (DOB) and sex) is collected on reports
however, there may be an opportunity to identify individ-
uals who appear in both HIV and hepatitis C surveillance
datasets by 'matching' individual reports.
In this exploratory study using national surveillance data,
we investigate whether existing national HIV and hepatitis
C surveillance systems can be used to estimate the number
of HIV-infected MSM in E&W diagnosed with sexually
transmitted hepatitis C in two ways. First, we try to match
individual case reports of HIV and hepatitis C diagnoses
between 1996–2003. Secondly, we try to match case
reports of HIV diagnoses with all hepatitis C test results
from laboratories participating in a sentinel surveillance
study during 2002–2003. This is the first time these
matching exercises have been conducted in E&W to exam-
ine sexually transmitted hepatitis C among HIV-infected
MSM.
Methods
Data sources
HIV diagnoses
Reports of HIV diagnoses are received by the Health Pro-
tection Agency (HPA) Centre for Infections from laborato-
ries (since 1985) and clinics (since 2000); the latter also
report new AIDS diagnoses (since 1982). Patient informa-
tion (soundex code of surname [13], DOB, sex) is col-
lected on all reports, enabling the identification of
multiple reports of the same individual without revealing
their identity or compromising confidentiality. A report
cannot be entered onto the system until all patient infor-
mation is complete. Missing information is followed up
with the laboratory or clinic. Probable route of infection
is also collected on all reports (i.e. sex between men, sex
between men and women, injecting drug use, blood trans-
fusion etc), and followed up where incomplete.
Hepatitis C diagnoses
Laboratory confirmed cases of hepatitis C have been rou-
tinely reported to the HPA Centre for Infections since the
early 1990s. Patient information (soundex code [13],
DOB, sex) is collected along with the likely route of infec-
tion, reporting laboratory and region of diagnosis. Unlike
HIV diagnoses, laboratory-confirmed hepatitis C cases are
not routinely followed up where information is missing,
so some reports do not have complete information on
soundex code, DOB, sex and how the infection was
acquired. A laboratory case is confirmed by the detection
of antibody to HCV (anti-HCV) or HCV RNA in serum.
Current available laboratory assays for HCV infection can-
not distinguish between acute and chronic infections.
While requests have been made for information on symp-
tomatic acute infections to be provided on laboratory
reports since 1996, this is rarely available.
Sentinel surveillance of hepatitis C testing
In the sentinel surveillance study of hepatitis C testing,
data were collected on all hepatitis C tests (negative, pos-
itive, equivocal) undertaken in eight laboratories (two in
London, six elsewhere in England) between January 2002
and December 2003 only [14]. Patient information
(soundex code, DOB, sex) was collected for each individ-
ual but was not followed up where missing. As for the rou-BMC Public Health 2007, 7:7 http://www.biomedcentral.com/1471-2458/7/7
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tine surveillance of hepatitis C diagnoses, a case was
confirmed by the detection of antibody to HCV (anti-
HCV) or HCV RNA in serum.
Matching exercise
(i) Matching individual HIV and hepatitis C diagnoses  
Laboratory reports of hepatitis C diagnoses made between
January 1996 and December 2003 (reports received by the
end of May 2004) were matched to reports of HIV diag-
noses since reporting began in 1982 through to December
2003 (reports received by end of September 2004).
Reports without enough patient information were
excluded. Exact matching was undertaken, for example,
where reports with exactly the same soundex code, DOB,
sex and reporting laboratory were identified. Further
matching was also undertaken to allow for errors in data
transcription. For example, soundex code, sex, reporting
laboratory, month and year of birth would be matched
exactly, allowing for errors in the transcription of the day
of birth. All matches were verified by eye.
(ii) Matching individual HIV diagnoses to reports from sentinel 
hepatitis C testing  
Reports from the sentinel surveillance of hepatitis C test-
ing from January 2002 to December 2003 were also
matched to reports of HIV diagnoses using the procedure
described above.
MSM identified with both hepatitis C and HIV diagnoses
are described as "co-diagnosed". Probable route of infec-
tion is recorded in both the HIV and hepatitis C labora-
tory diagnoses datasets and in the sentinel surveillance of
hepatitis C testing. Co-diagnosed MSM were assumed to
have acquired their hepatitis C infection as a result of sex
with another man if no other risks (e.g. injecting drug use)
were reported in either dataset. Men with other risks were
excluded from the analysis.
Patient confidentiality and ethics
In England and Wales, reports of HIV diagnoses and diag-
noses of hepatitis C infection are voluntary and confiden-
tial. To maintain patient confidentiality no names are
held on the HIV database; soundex codes (a pseudonomy-
ised code of a surname) are used instead [13]. The report-
ing systems have approval under the section 60
regulations of the Health and Social Care Act 2001 (Stat-
utory Instrument 1438 – June 2002). All data are stored
on restricted and secure databases at the HPA, with strict
adherence to the Data Protection Act and Caldicott Guide-
lines [15]. Ethical approval was obtained for the sentinel
surveillance of hepatitis C testing from the Northern and
Yorkshire Multi-Centre Research Ethics Committee
(MREC1/3/76) and the Public Health Laboratory Service
Ethics Committee.
Results
Matching individual HIV and hepatitis C diagnoses
Of the 38,027 hepatitis C infections diagnosed between
1996 and 2003 and reported to the HPA, 68% (25,938/
38,027) were eligible for inclusion in the matching exer-
cise. The number and proportion of hepatitis C laboratory
reports eligible for inclusion rose over time, from 50%
(1,256/2,499) in 1996 to 74% (4,749/6,448) in 2003.
The number of reports and degree of matching varied by
region (table 1).
The matching exercise identified 199 individuals diag-
nosed with both hepatitis C and HIV ("co-diagnosed") of
whom 47 were men who reported sex with another man
(MSM) (table 2). Of the 47 co-diagnosed MSM, 16 were
recorded as having injected drugs, having received a blood
transfusion or blood factor products. These 16 MSM were
therefore excluded from further analysis as they may not
have acquired hepatitis C sexually.
For the 31 remaining MSM with no other reported risk,
median time between HIV and hepatitis C diagnoses was
26 months (IQR: 4–90 months); 22 were diagnosed with
hepatitis C after their HIV diagnosis, three before and six
in the same year. Median age at HIV diagnosis was 32
years and at hepatitis C diagnosis, 36 years. A rise in the
number of co-diagnosed MSM was observed over time,
from zero in 1996 to 14 in 2003 (figure 1).
Twelve of the 31 MSM were diagnosed with hepatitis C in
the North West, five in the South West, four in London,
four in the West Midlands, three in East Midlands and
three elsewhere (figure 2a). Where ethnicity was reported
(n = 25), the majority (n = 23) were white, while two were
black Caribbean. Where probable country of HIV infec-
tion was reported (n = 16), 75% (12) were infected with
HIV in the UK
Matching individual HIV diagnoses to reports from sentinel 
hepatitis C testing
Of the 78,058 individuals tested for hepatitis C in 2002 or
2003 by laboratories participating in the sentinel surveil-
lance of hepatitis C testing, 87% (67,712/78,058) were
eligible for inclusion in the matching exercise. Overall,
6% of the 78,058 individuals were tested at GUM clinics
but records from GUM clinics represented 40% of the
10,346 excluded records (i.e. 82% of records from GUM
clinics were excluded). This is because GUM clinics do not
usually report soundex code/surname on laboratory test
request forms. The number and proportion of hepatitis
test results eligible for inclusion varied by region (table 1),
reflecting both the sentinel nature of the surveillance sys-
tem and the quality of patient information recorded.BMC Public Health 2007, 7:7 http://www.biomedcentral.com/1471-2458/7/7
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Table 2: Probable route of HIV infection and hepatitis C risk for individuals identified as 'co-diagnosed' through matching
Probable route of HIV infection Probable route of hepatitis C infection Number of "co-diagnosed"
Sex between men Injecting drug use 4
Blood transfusion/product 1
No risk reported 31
Sex between men & injecting drug use Injecting drug use 2
No risk reported 9
Injecting drug use Injecting drug use 33
Heterosexual intercourse 1
No risk reported 61
Heterosexual intercourse Injecting drug use 2
Heterosexual intercourse 1
No risk reported 26
Blood transfusion/product Blood transfusion/product 5
No risk reported 18
Not reported Injecting drug use 1
No risk reported 4
Total 199
Table 1: Number of HIV diagnoses, hepatitis C laboratory diagnoses and reports from the sentinel surveillance of hepatitis C testing 
received and eligible for inclusion in the matching exercise by region of diagnosis/test
Region of diagnosis/test HIV diagnoses 
(1982–2003)
Hepatitis C laboratory diagnoses 
(1996–2003)
Sentinel surveillance of hepatitis C testing 
(2002–2003)
No of diagnoses No of 
reports
No included in the 
matching exercise*
No of 
reports
No included in the matching exercise*
n % n %
East Midlands 1675 1721 1017 59 8337 7927 95
Eastern 2561 3859 2488 64 na na na
London 35401 2630 1822 69 3187 2959 92
North East 848 926 693 75 11814 9848 83
North West 3840 8107 6280 77 31576 27381 87
South East 5514 5655 3615 64 na na na
South West 1937 5748 4441 77 na na na
West Midlands 2454 4345 2895 67 9489 7282 76
Yorkshire & Humberside 2246 2162 1639 76 13513 12315 91
Wales 864 2874 1028 36 na na na
Total 57340 38027 25918 68 78058 67712 87
*reports were excluded from the matching exercise if patient information was missing or there were other anomalies.
na=not availableBMC Public Health 2007, 7:7 http://www.biomedcentral.com/1471-2458/7/7
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The matching exercise identified 782 individuals who
tested for hepatitis C in 2002–2003, who had also been
diagnosed with HIV. Of these 782 individuals, 319 were
MSM. Five of these men also had a history of injecting
drug use and so were excluded from further analysis. Of
the remaining 314 MSM with an HIV diagnosis who had
had a hepatitis C test, 13 (4.1%) tested hepatitis C positive
(95% confidence interval: 2.2%, 7.0%). Data for 2002
only: 2.8% (2/72) hepatitis C positive (95%CI: 0.3% to
9.7%). Data for 2003 only: 4.5% (11/242) hepatitis C
positive (95%CI: 2.3% to 8.0%).
Median age at hepatitis C testing was 40 years and for HIV
diagnosis, 33 years, which did not vary by hepatitis C test
result. The percentage of MSM with diagnosed HIV who
tested positive for hepatitis C varied between regions (fig-
ure 2b). Where ethnicity was reported on HIV reports,
94% (204/216) were white, again not varying by test
result. Where probable country of HIV infection was
reported, most MSM (134/155) were infected with HIV in
the UK.
In 2003, 15,121 MSM with an HIV diagnosis were seen for
treatment and care in E&W [16]. If 4.5% of these men
tested positive for hepatitis C (assuming the same percent-
age tested positive in the overall MSM population seen for
HIV-related care as seen here), we estimate that 680 MSM
living with diagnosed HIV in E&W tested positive for sex-
ually transmitted hepatitis C in 2003 (95%CI: 346 to
1208).
Discussion
By matching individual hepatitis C and HIV diagnoses in
England and Wales between 1996–2003, we identified 31
HIV-infected MSM with sexually transmitted hepatitis C
infection, of whom only four were in London. Clinical
studies suggest that this is a substantial underestimate
[1,8]. For example, at one central London GUM clinic
alone, 26 HIV positive MSM were diagnosed with sexually
transmitted hepatitis C between 1997 and 2002. Across
six large GUM clinics in London and Brighton, 225 HIV
positive MSM with sexually transmitted hepatitis C were
identified between October 2002 and August 2005 [1,8].
On the other hand, matching HIV diagnoses and hepatitis
C tests from sentinel sites suggested that, in 2003, nearly
five percent of MSM diagnosed with HIV who were tested
for hepatitis C were found to be positive. Sexual transmis-
sion of hepatitis C was the likely route of infection. While
this matching exercise was more successful, the true per-
centage may be underestimated since those attending
GUM clinics, and likely to be at higher risk because of
their sexual behaviours, were less likely to be included in
the analysis because of a lack of patient identifiable infor-
mation.
The percentage of HIV-infected individuals (mainly MSM)
testing hepatitis C positive rose over time in a London
GUM clinic, from 0.6% in 1996 to 9.3% in 2002 [1]. The
estimates from our sentinel sites for 2002 and 2003 were
more conservative (2.8% and 4.5%, respectively). Assum-
ing that these percentages can be applied to all HIV posi-
tive MSM receiving treatment and care, we estimate that,
in 2003, at least 680 MSM (95%CI: 346 to 1208) with
diagnosed HIV tested positive for sexually transmitted
hepatitis C in E&W.
Our analysis also shows that sexually transmitted hepati-
tis C among HIV-infected MSM is not confined to London
and Brighton. Outside London, the number of HIV
infected MSM with sexually transmitted hepatitis C infec-
tion was highest in the North West, which includes Man-
chester with a large MSM population and good reporting
of both HIV and hepatitis C diagnoses (table 1) [unpub-
lished, HPA]. Again however, these figures are likely to be
underestimates due to a lack of reported patient identifia-
ble information.
Limitations of current surveillance systems
Our analyses are dependent on MSM being diagnosed
with HIV and hepatitis C infection: both infections may
be asymptomatic for a significant length of time and some
may have died without being diagnosed with HIV and/or
hepatitis C. The analyses also rely on MSM diagnosed with
hepatitis C and/or HIV being reported to national surveil-
lance systems. The hepatitis C laboratory data appeared to
be poorly reported in London (table 1), relative to the
number of diagnoses in other regions. Incomplete report-
ing within a region will affect the number of hepatitis C
reports that can be matched to HIV diagnosis reports, and
subsequently the number of co-diagnoses detected in that
Number of MSM co-diagnosed with hepatitis C and HIV in  England and Wales identified through the matching exercise,  by year of hepatitis C diagnosis Figure 1
Number of MSM co-diagnosed with hepatitis C and HIV in 
England and Wales identified through the matching exercise, 
by year of hepatitis C diagnosis.
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area. In addition, for the sentinel surveillance of hepatitis
C testing, only two small London laboratories were
included. These laboratories do not serve GUM clinics
with large MSM populations and are not necessarily rep-
resentative of all MSM testing for hepatitis C in London.
On the other hand, many of the sentinel sites outside Lon-
don were large laboratories in major provincial cities
(Manchester, Leeds, Birmingham, Nottingham and New-
castle) so it is likely that a substantial number of MSM
receiving HIV care outside London were included.
There are limitations to the matching process: individuals
may be incorrectly matched or individuals may not be
matched if information has been incorrectly recorded.
Reports must also contain sufficient information for the
matching process; overall nearly a third of the hepatitis C
laboratory reports and more than ten percent of the hepa-
titis C test requests from sentinel surveillance could not be
matched to HIV diagnoses because of missing patient
information. This varied by region, and for hepatitis C
diagnoses, over time. In the sentinel surveillance study,
the majority of records for GUM clinic attendees, who
may be at higher risk of acquiring HIV and sexually trans-
mitted hepatitis C infection, had to be excluded because
of a lack of reported soundex code/surname. Incomplete
reporting will lead to underestimation and introduce bias,
particularly in London. On the other hand, increases in
hepatitis C testing and improvements in the reporting of
patient information on laboratory diagnoses of hepatitis
C may have led to improved ascertainment of co-diag-
nosed individuals over time. There may also be a bias in
that hepatitis C testing might have been prompted by
abnormal liver function tests or by injecting drug use that
had not been disclosed at the time of HIV diagnosis.
Conclusion
It was not possible to use current national surveillance sys-
tems to accurately monitor sexually transmitted hepatitis
C infection among HIV-infected MSM across E&W. The
number of HIV infected MSM with sexually transmitted
hepatitis C infection was underestimated due to the limi-
tations of the surveillance systems, particularly reporting
of hepatitis C diagnoses, the matching process, and the
sentinel nature of the hepatitis C testing data. Improved or
enhanced surveillance methods (such as for lymphogran-
uloma venereum (LGV)) are needed to monitor sexually
transmitted hepatitis C infection among HIV-infected
MSM nationally, as well as in London. The recording of
soundex codes and dates of birth on test request forms
from GUM clinics would also improve the quality of sur-
(a) Number of co-diagnosed MSM (1996–2003) and (b) proportion of diagnosed HIV-infected MSM with a positive hepatitis C  test (2002–2003) by region of hepatitis C diagnosis/test in England and Wales, as identified through the matching exercise Figure 2
(a) Number of co-diagnosed MSM (1996–2003) and (b) proportion of diagnosed HIV-infected MSM with a positive hepatitis C 
test (2002–2003) by region of hepatitis C diagnosis/test in England and Wales, as identified through the matching exercise.BMC Public Health 2007, 7:7 http://www.biomedcentral.com/1471-2458/7/7
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veillance data. Nonetheless, our study provides some
insight into an area of gay men's sexual health where there
is currently a paucity of information at a national level.
Until now, studies have focused on MSM in London, but
our results suggest that sexual transmission of hepatitis C
infection has been reported among HIV positive MSM
throughout E&W. This merits further investigation. An
evaluation of the most appropriate hepatitis C testing
algorithms for MSM with HIV also needs to be under-
taken.
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